Measure Title: RELATING TO PRESCRIPTION DIGITAL THERAPEUTICS.
Report Title: Department of Health; Feasibility Study; Pilot Program; Prescription Digital Therapeutics; Outpatient Treatment; Substance Use Disorder; Opioid Use Disorder
Description: Requires the Department of Health to conduct a study to determine the feasibility of implementing a pilot program to integrate prescription digital therapeutic products approved by the federal Food and Drug Administration in outpatient treatment programs for persons with substance use disorder and persons with opioid use disorder in the State. Requires a report to the Legislature. Effective 12/31/2050. (SD1)
Companion:
Package: None
Current Referral: HHS, WAM
Introducer(s): KEOHOKALOLE, AQUINO, LEE, MCKELVEY, Ihara, Wakai
Act:

Sort by Date Status Text
12/11/2023DCarried over to 2024 Regular Session.
2/17/2023SReport adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.
2/17/2023SReported from HHS (Stand. Com. Rep. No. 459) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.
2/6/2023SThe committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Moriwaki, Shimabukuro; Aye(s) with reservations: none ; 1 No(es): Senator(s) Awa; and 0 Excused: none.
2/3/2023SThe committee(s) on HHS has scheduled a public hearing on 02-06-23 1:00PM; Conference Room 225 & Videoconference.
1/25/2023SReferred to HHS, WAM.
1/20/2023SPassed First Reading.
1/20/2023SIntroduced.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB446 SD1
All Versions of this Measure
Committee Reports
Hearing Notices
HHS
2/06/23 1:00P
CR 225 & Videoconference